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Summary
 
We have used intravital microscopy to study physiologically perfused microvessels in murine
bone marrow (BM). BM sinusoids and venules, but not adjacent bone vessels, supported rolling
interactions of hematopoietic progenitor cells. Rolling did not involve L-selectin, but was par-
tially reduced in wild-type mice treated with antibodies to P- or E-selectin and in mice that
were deficient in these two selectins. Selectin-independent rolling was mediated by 
 
a
 
4 inte-
grins, which interacted with endothelial vascular cell adhesion molecule (VCAM)-1. Parallel
contribution of the endothelial selectins and VCAM-1 is not known to direct blood cell traf-
ficking to other noninflamed tissues. This combination of constitutively expressed adhesion
molecules may thus constitute a BM-specific recruitment pathway for progenitor cells analo-
gous to the vascular addressins that direct selective lymphocyte homing to lymphoid organs.
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T
 
he bone marrow (BM)
 
1
 
 is a site of intense cellular traf-
fic from the hematopoietic compartment to the pe-
ripheral blood and vice versa. This vital process requires the
formation and release of adhesive bonds between blood
cells and BM stroma cells in both the extra- and intravascu-
lar space. Some adhesion molecules recently have been im-
plicated in the release of hematopoietic stem cells into the
systemic circulation (1, 2). However, little is known about
the adhesion pathways that are involved in the homing of
hematopoietic stem cells and hematopoietic progenitor
cells (HPCs) from the blood to the BM. It is likely that a
critical step in this process is the adhesion of blood-borne
cells to the lining of BM microvessels in the presence of
physiologic fluid shear that is exerted by the blood stream.
Extensive studies on mature leukocytes in the microcircu-
lation of a number of other organs have demonstrated that
cells must undergo a sequence of distinct adhesion steps to
accumulate in a tissue (3, 4). Most adhesion cascades are
initiated by a primary tethering event mediated by selectins
and their carbohydrate ligands that allows cells to roll
slowly along the wall of postcapillary venules. Subse-
quently, when a rolling cell encounters a chemoattractant
that binds to surface receptors, an intracellular signaling cas-
cade is triggered that induces the functional upregulation of
integrins. Integrins then bind to endothelial counterrecep-
tors, mediating firm arrest of the rolling leukocyte. Subse-
quently, leukocytes migrate through the blood vessel wall
and enter the extravascular tissue.
Due to the anatomic inaccessibility of most BM mi-
crovessels, it is not known whether a similar multistep pro-
cess can also occur in BM microvessels. A detailed knowl-
edge of these events is important since the success of BM
and stem cell transplantations depends on the efficient seed-
ing of grafted cells in the recipient’s BM. BM transplanta-
tion studies have shown that the 
 
a
 
4 integrin/vascular cell
adhesion molecule (VCAM)-1 (CD49d/CD106) pathway
and one or more unidentified lectins determine in part the
recovery of colony-forming units from the BM of irradi-
ated mice (5, 6). However, little is known about the site of
action and the mechanisms through which these and per-
haps other molecules contribute to HPC homing. Recent
data indicate that murine and human BM endothelium
 
1
 
Abbreviations used in this paper:
 
 BM, bone marrow; BV, bone venule; CN,
capillary network; CV, collecting venule; FDCP-mix, factor-dependent
cells Paterson-mix; FL, fetal liver; F/P, fluorescein/protein; HPC, hema-
topoietic progenitor cells; IV, intermediate venule; PSV, postsinusoidal
venule; VCAM, vascular cell adhesion molecule.
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constitutively expresses VCAM-1 (7, 8), suggesting that
VCAM-1 may be involved in the trafficking of cells be-
tween blood and BM.
The role of selectins in HPC trafficking is also unclear. Ev-
idence that carbohydrate–protein interactions may be in-
volved in homing of HPCs to BM was acquired some time
ago (6). It is known that L-selectin is expressed on the major-
ity of HPCs (9-11), but its function on these cells is unclear.
No hematopoietic defects have been described in L-selectin
knockout mice (12). HPCs were also shown to bind to
P-selectin (13), although the expression of P-selectin on BM
endothelial cells has not been described. Recent data suggest
that E-selectin is constitutively expressed on endothelial cells
of human and murine hematopoietic tissues (8, 14), but the
role of E-selectin in HPC homing has not been addressed.
We describe a novel technique to visualize and dissect
interactions of HPCs with BM microvessels in the skulls of
anesthetized mice. This model allows the direct micro-
scopic observation and quantitative analysis of adhesion
events in physiologically perfused BM microvessels. Using
this approach, we have characterized the anatomy and he-
modynamics of the skull BM microvasculature, and we
demonstrate that HPCs roll in BM venules and sinusoids in
the absence of inflammation. Using neutralizing antibodies
and genetically deficient mice, we show that HPC rolling is
mediated by parallel contributions of constitutively ex-
pressed P- and E-selectin and VCAM-1.
 
Materials and Methods
 
Antibodies.
 
Anti-
 
a
 
4 mAb PS/2, anti-LFA-1 mAb Tib 213,
anti–L-selectin mAb Mel-14, and anti–MAdCAM-1 mAb Meca-
367 were provided by Dr. E.C. Butcher (Stanford University,
Stanford, CA). Anti–VCAM-1 mAb MK 2.7, anti–P-selectin
mAb 5H1, and anti–E-selectin mAb 10E6 were a gift from Dr. B.
Wolitzky (Hoffmann-La Roche Inc., Nutley, NJ). All mAbs
were purified from hybridoma supernatants and stored at 
 
2
 
70
 
8
 
C
in LPS-free saline. Aliquots of mAbs Meca-367 and MK 2.7 were
fluoresceinated with carboxyfluorescein succinimidyl ester (Mo-
lecular Probes, Eugene, OR). Fluorescein/protein (F/P) ratios
were 6.94 and 2.85, respectively. FITC- and PE-conjugated mAbs
to murine c-kit, Ter-119, Mac-1, and CD34 were purchased from
PharMingen (San Diego, CA). FITC- and PE-labeled goat anti–
rat IgG was from Caltag Labs. (South San Francisco, CA).
 
Cells.
 
The murine progenitor cell lines factor-dependent
cells Paterson-mix (FDCP-mix) and M1 were grown as previ-
ously described (15, 16). For in vivo experiments, cells were fluo-
rescently labeled with 2
 
9
 
,7
 
9
 
-bis-(carboxyethyl)-5(and-6) carboxy-
fluorescein (BCECF; Molecular Probes). After staining for 30
min at 37
 
8
 
C (2 
 
m
 
g BCECF/10
 
7
 
 cells), cells were washed and re-
suspended to 10
 
7 
 
cells/ml in RPMI 1640 (BioWhittaker, Walk-
ersville, MD) containing 10% fetal bovine serum.
To generate fetal liver (FL) HPCs, female and male C57BL/6J
mice were mated following standard procedures. Pregnant fe-
males were killed 11 d after first observation of a vaginal plug. FLs
were dissected from embryos and sieved through a nylon mesh
(Becton Dickinson, San Jose, CA). Cells were washed and resus-
pended in IMDM (BioWhittaker), and viability was determined
by trypan blue exclusion. Fluorescent labeling with BCECF was
as described for FDCP-mix cells.
Unlabeled aliquots of cell lines and FL cells were transferred to
ice for mAb staining and flow cytometric analysis of surface mole-
cules; all other cells were kept at 37
 
8
 
C throughout the experiment.
Fluorescently labeled red blood cells from C57/Bl6J donor mice
were used to assess BM microhemodynamics. 0.5 ml of anticoagu-
lated blood was washed in 1.0 ml PBS, resuspended in PBS to a
10% hematocrit (based on pellet size), layered on Histopaque-1077
(Sigma Chemical Co., St. Louis, MO), and centrifuged for 8 min at
900 rpm to remove leukocytes. The pellet was resuspended to a 5%
hematocrit in DMEM (BioWhittaker) with glucose, and 0.5 mg/ml
BCECF was added. The cells were incubated at 37
 
8
 
C for 40 min,
washed, and resuspended to 5% hematocrit in PBS for injection.
 
Animals.
 
Adult C57/Bl6J
 
3
 
129S mice of both sexes were
used in these studies.
 
 
 
P
 
/
 
E-selectin double knockout mice on the
same genetic background have been described previously (14).
Animals were kept in a viral antigen–free barrier facility on stan-
dard lab chow and sterile water supply ad libidum. This study
complies with National Institutes of Health guidelines for the care
and use of laboratory animals.
 
Animal Preparation.
 
Mice were anesthetized by intraperitoneal
injection (10 ml/kg) of physiologic saline containing ketamine
(5 mg/ml) and xylazine (1 mg/ml). The hair in the submandibular
area of the neck and on the skullcap was removed using hair
removal lotion (Nair, Carter Products, NY). PE-10 polyethylene
catheters (Becton Dickinson) were inserted into the left jugular
vein for administration of fluids and into the right common caro-
tid artery for injection of fluorescent cells into the aortic arch. The
scalp was incised in the midline and the frontoparietal skull was
exposed while carefully avoiding damage to the bone tissue. A
plastic ring was inserted in the incision to spread the skin and to
allow application of sterile physiologic saline solution to prevent
drying of the tissue. To immobilize the animal’s head, the mouse
was placed on a customized plexiglas stage equipped with a stereo-
tactic holder (David Kopf Instruments, Tujunda, CA).
 
Intravital Microscopy.
 
An intravital microscope (IV 500; Mi-
kron Instruments, San Diego, CA) equipped with water immer-
sion objectives (Carl Zeiss, Inc., Thornwood, NY) was used in
experiments. Small boluses (
 
z
 
50 
 
m
 
l) of BCECF-labeled cells
were injected through the right carotid artery catheter. Fluores-
cent cells were visualized in the left frontoparietal skull by video-
triggered stroboscopic epi-illumination (Chadwick Helmuth, El
Monte, CA) through an FITC filter set and an 
 
3
 
10 objective
(Zeiss Achroplan, numerical aperture [NA] 0.3 
 
¥
 
, Water). 150
kD of FITC dextran (Sigma Chemical Co.) was injected in some
experiments for measurements of microvascular dimensions using
an 
 
3
 
40 objective (Zeiss Achroplan, NA 0.75 
 
¥
 
, Water) as previ-
ously described (17). At the end of some experiments, saline con-
taining 1 mg/ml rhodamine 6G or 4 mg/ml rhodamine 123
(Molecular Probes) was injected intravenously at a dose of 1.5
ml/kg body weight. The distribution of FITC-dextran (Sigma
Chemical Co.) and rhodamine compounds in the skull was re-
corded through an 
 
3
 
4 objective (Achroplan, NA 0.16). All
scenes were recorded on video tape using a SIT camera (VE
1000-SIT; Dage MTI, Michigan City, IN), a time base generator
(For - A, Montvale, NJ), and a Hi-8 VCR (Sony, Boston, MA).
 
Image analysis.
 
62 representative BM venules and sinusoids
were analyzed to measure luminal cross-sectional diameter and ve-
locity of labeled erythrocytes (
 
$
 
20 cells/vessel) using a PC-based
image analysis system (18). The wall shear rate was calculated for
each venule as previously described (17, 19). Rolling fractions of
progenitor cell lines and FL HPCs were determined by counting
the number of interacting cells in each venule or sinusoid per 100
cells that passed through the same vessel during an injection. 
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Histology.
 
The frontoparietal bones of murine skulls were
explanted and fixed for 6 h in PBS containing 4% paraformalde-
hyde, decalcified (Accumate RDO; Sigma Chemical Co.) and em-
bedded in paraffin in a Tissue-Tec vacuum infiltration processor
(Miles Labs., Inc., Somerset, MA). Frontal sections were cut (5-
 
m
 
m
thick) with a microtome (Reichert-Jung, Nussloch, Germany) and
stained with hematoxylin and eosin following standard procedures.
 
Culture Colony-Forming Unit Assay.
 
Frontoparietal bones, fem-
ora, and brains of five mice were ground using a mortar and pes-
tle. Single cell suspensions were generated and mononuclear cells
(MNCs) were isolated by density gradient centrifugation over Fi-
coll-Hypaque (Sigma Chemical Co.). Colonies were grown in
IMDM containing 15% fetal bovine serum (JRH Biosciences,
Lenexa, KS), 1% bovine serum albumin (Sigma Chemical Co.),
0.13 mM 
 
b
 
-mercaptoethanol (Sigma Chemical Co.), 2.5 U/ml
recombinant erythropoietin (Amgen, Inc., Thousand Oaks, CA),
150 ng/ml recombinant mouse stem cell factor (Sigma Chemical
Co.), and 10% (vol/vol) 
 
3
 
63 IL-3–conditioned medium. Isolated
MNCs, 1 ml/well, were plated in duplicate in 0.9% methylcellulose
(Sigma Chemical Co.) at 10
 
5
 
 and 3 
 
3 
 
10
 
5 
 
cells/ml. Cultures were
maintained at 37
 
8
 
C in 5% CO
 
2
 
. Colonies were counted after 8 d.
 
FACS
 
Ò
 
 Analysis.
 
Surface expression of adhesion molecules
by FDCP-mix, M1, or FL HP cells was assessed by flow cytome-
try: the cells were suspended to 10
 
7
 
 cells/ml in RPMI 1640 and
kept on ice; 20 
 
m
 
g/ml of mAbs to L-selectin, 
 
a
 
4, LFA-1, Mac-1,
 
b
 
7, cutaneous lympohocyte antigen (CLA), and P-selectin glyco-
protein ligand (PSGL)-1 were added to 100 
 
m
 
l cell suspension.
Cells were washed twice after 30 min of staining, and FITC- or
PE-conjugated goat anti–rat IgG was added in a dilution of 1:100
or 1:200, respectively. Subsequently, cells were washed twice af-
ter 30 min of staining and analyzed using a FACScan
 
Ò
 
 flow cy-
tometer (Becton Dickinson). For two-color flow cytometry cells
were incubated with 1:200 diluted rat sera (Sigma Chemical Co.)
for 15 min on ice to decrease nonspecific binding of antibody and
washed. Subsequently cells were incubated on ice with PE- and
FITC-conjugated mAbs (30 min each incubation) with two
washings between each incubation.
 
Statistical Methods.
 
For statistical comparison of two samples,
a two-tailed Student’s 
 
t
 
 test was used when applicable. Multiple
comparisons were performed using the Kruskal-Wallis test with
Bonferoni correction of 
 
P
 
. Differences were considered statisti-
cally significant when
 
 P 
 
,
 
0.05. Data are presented as mean 
 
6
 
SEM unless indicated otherwise.
 
Results and Discussion
 
Anatomy of the Microcirculation in the Murine Frontoparietal
Skull.
 
We noticed that the flat bones which form the
skull’s calvaria contain BM that was macroscopically visible
as a red coloration, primarily in the parasagittal region (Fig.
1
 
 A
 
, 
 
left
 
). Visually identified red BM was located often in
the interparietal bone parallel to the lambdoidal suture, but
the microvascular network in this area was frequently
sparse and poorly visible. In contrast, the thin layer of bone
that covered the BM cavities in the frontoparietal skull was
sufficiently transparent to allow the observation of a multi-
tude of underlying microvessels without the need for surgi-
cal manipulation of the bone itself. Thus, the microvascular
network in this area of the skull could be studied in the
absence of trauma-induced hemorrhage or significant in-
flammation.
To characterize the microvascular anatomy, we intrave-
nously injected FITC-dextran, an inert plasma marker that
facilitates measurements of luminal dimensions (17) (Fig. 1
 
A
 
, 
 
right
 
). Although there was considerable heterogeneity
between animals, several distinguishing features of the fron-
toparietal skull microcirculation were noted. The most
prominent vessel was a large collecting venule (CV) that
was often macroscopically detectable. This venule was bi-
laterally located in the frontal bone in close proximity and
parallel to the coronal suture and drained into the superior
sagittal sinus. The function of this venule may be analogous
to that of the central vein in the BM of long bones. The
BMCV received afferent blood from a parietal network of
sinusoids that were irregularly shaped, frequently arranged
in a honeycomb pattern, and linked by short anastomoses.
The direction of blood flow in some of these anastomosing
vessels fluctuated unpredictably. Most laterally positioned
sinusoids drained directly into the BMCV, whereas blood
from medially located sinusoids reached the BMCV via one
or more postsinusoidal venules (PSV). BMCV also received
blood from laterally located venules in the frontal bone.
These vessels included both elongated bone venules (BV)
that had few branches and no apparent contact to BM cav-
ities and a number of intermediate venules (IV) with nu-
merous branches that were surrounded by a variably thick
layer of BM tissue. Diameters of BMCV, sinusoids, and
BMPSV did not differ significantly from each other, whereas
BMIV were more narrow (Table 1).
In addition to the vessels described above, we noted
parasagittal capillary networks (CNs) in the frontal and inter-
parietal bones. Blood flow in CN vessels (diameter: 10.9 
 
6
 
2.2 
 
m
 
m, mean 
 
6 
 
SD) was typically low and highly variable
and was often partially obscured by extravascular erythroid
cells which seemed more concentrated in this area than else-
where. The adhesive phenomena observed in the frontal CNs
were consistent with those from other regions of the skull.
However, these data were not included in the results described
below because only few cells entered this area and due to poor
visibility it was often not possible to distinguish between flow-
related slowing and adhesive interactions of cells.
 
Microvascular Hemodynamics in the Skullcap.
 
To assess BM
microhemodynamics, fluorescently labeled murine eryth-
rocytes were injected intraarterially and their velocity in
BM venules and sinusoids was determined by off-line video
analysis as previously described (17). Mean blood flow ve-
locities and wall shear rates in BM sinusoids, BMPSVs, and
BMCVs were similar except in BMIVs, where these pa-
rameters were lower (Table 1). These measurements of mi-
crovascular hemodynamics and dimensions are in good
agreement with earlier studies of blood flow in BM micro-
vessels of the rabbit fibula (20) and with ultrastructural
measurements of BM sinusoids in guinea pigs (21).
 
Intravenously Injected Rhodamine Fluorophores Delineate He-
matopoietic Tissue within BM Cavities.
 
Previous studies on
the ultrastructure of BM samples have shown that the walls
of many microvessels are discontinuous, i.e., they partly
lack a basal lamina and adventitial cells (21). However, we
did not detect FITC-dextran (150 kD) extravasation from 
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Figure 1. Anatomy and histology of murine skull BM. (A) Top view of the dorsal murine skull. Major flat
bones and sutures are shown schematically (left). The rectangle over the frontoparietal region indicates the area
which shows the typical microvascular anatomy after intravenous injection of 150-kD FITC-dextran (right). A
large BMCV (1) in the parietal bone parallel to the coronal suture drains into the sagittal sinus (2). A parietal
network of sinusoids (3) drains into the BMCV, either directly or via one or more BMPSV (4). BMCVs also
receive blood from laterally located venules in the parietal bone. These vessels include BMIVs (5) and some
BVs (6). A dense parasagittal CN (7) is located in the frontal bone. Blood flow in CN capillaries is highly vari-
able and often partially obscured by red marrow, which tends to be more concentrated in this area than else-
where. (B) Rhodamine 6G accumulation. A marked accumulation of the dye (R) is observed in the parasagittal
regions of frontal and parietal bones and in the perivascular space of sinusoids and some, but not all, venules.
Identical staining patterns were seen with rhodamine 123 (data not shown). Number designations are as in A.
(C) Photomicrographs of hematoxylin and eosin–stained frontal sections through the frontal bones of a skull.
The sections lie approximately on the long axis of the quadrangle in A (left). Several intraosseous cavities filled with densely packed hematopoietic cells
are shown at low magnification (top). Arrows indicate the sagittal (left) and coronal (right) sutures; SS, sagittal sinus. At higher magnification (bottom), a mi-
crovessel (*) can be detected within a BM cavity. Scale bars in top and lower panels depict 500 and 50 mm, respectively. (D) Colony-forming capacity of
MNCs from murine brain, skull, and femur. MNCs isolated from brains, skullcaps, and femora of five mice were harvested and plated on methylcellulose.
CFU-C assays were performed in duplicate. Data are expressed as mean 6 SEM of three independent experiments.
 
BM vessels, indicating that skull BM endothelium consti-
tutes an efficient barrier to blood-borne macromolecules. In
contrast, when the low molecular weight fluorophores
rhodamine 6G (479 dalton) or rhodamine 123 (381 dalton)
were injected intravenously, intense extravascular labeling
was observed in a bizarrely shaped, sharply demarcated, and
approximately symmetrical pattern in parasagittal areas of the
frontal, parietal, and interparietal bones. Contained within 
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these regions were the dense CNs, sinusoids, BMPSVs,
BMCVs, and BMIVs, but not BVs (Fig. 1 
 
B
 
).
The conspicuous staining pattern with rhodamine com-
pounds was unique to the skull calvaria; we did not observe
a similar extravascular distribution of rhodamine 6G in
other murine tissues including skin, cremaster muscle,
lymph node, small intestine, and Peyer’s patches, although
microvessels in some organs (especially the gut) appear to
be similarly permeable to rhodamine 6G (von Andrian,
U.H., unpublished data). Therefore, the restricted distribu-
tion of rhodamine suggested the presence of anatomically
confined compartments. To test this, we performed a his-
tologic examination of coronal sections of paraffin-embed-
ded skull caps (Fig. 1 
 
C). The frontoparietal skull contained
intraosseous BM cavities that were filled with densely
packed hematopoietic cells of various lineages and perme-
ated by numerous microvessels. The intense intravital stain-
ing of these areas implies that many cells were metabolically
active because both rhodamine compounds preferentially
stain mitochondria (22). Indeed, this property of rhoda-
mine 123 has been exploited to assess the degree of HPC
differentiation (23).
Murine Skullcap BM Contains Hematopoietic Progenitor
Cells. To confirm that skull BM cavities contained HPCs,
we performed CFU-C assays in methylcellulose with MNCs
isolated from skull caps, femora, and brains of adult mice. In
three independent experiments, plated cells from skulls and
femora, but not from brains, gave rise to granulocyte/mac-
rophage and erythroid colonies (3,908 6 238 and 5,331 6
841 colonies per 106 MNCs, respectively, mean 6 SEM;
Fig. 1 D). The commitment of HPCs to these two lineages
reflects the composition of growth factors in our assay and
does not exclude the presence of lymphoid progenitors and
megacaryocytes in the skull. The difference in the fre-
quency of colonies in CFU-C assays using MNCs from
skulls and femora was not statistically significant. We con-
clude that the hematopoietic tissue within the cavities of
adult murine calvaria contains HPCs at a similar frequency
as the marrow of the long bones.
BM Venules and Sinusoids Support Constitutive Rolling In-
teractions of FDCP-mix Cells. Having established that we
can identify and analyze BM microvessels, we tested the
adhesive behavior of FDCP-mix cells, a murine cell line
with HPC-like properties. This is a growth factor (IL-3)–
dependent multipotential cell line that can proliferate in the
presence of horse sera without differentiating (15). Fluores-
cently labeled cells were injected through a carotid artery
catheter and their passage through the BM was recorded
(Fig. 2 A). FDCP-mix cells rolled in most BM venules and
sinusoids, but rarely interacted with BV (Fig. 2 B). Within
different types of BM microvessels rolling fractions were
variable, but they were always significantly higher than in
adjacent BVs. We conclude that BM microvessels are dis-
tinguishable from BV not only by their shape, localization,
and perivascular accumulation of rhodamine compounds,
but also by their distinct adhesive properties.
Constitutively Expressed E- and P-selectin, but not L-selectin,
Participate in FDCP-mix Cell Rolling in BM Microvessels.
Next, we set out to identify the molecular mechanisms of
progenitor cell rolling. The three selectins have been shown
to mediate rolling of mature leukocytes in many other or-
gans (24). Flow cytometric analysis indicated that FDCP-
mix cells express L-selectin, P-selectin glycoprotein ligand
(PSGL)-1, and low levels of the cutaneous lymphocyte anti-
gen (CLA; data not shown). The latter two are ligands for
endothelial P- and E-selectin, respectively (25, 26). A simi-
lar pattern of selectins and their ligands was found on hu-
man CD341 HPCs (13), which supports the validity of us-
ing FDCP-mix cells as a model for stem cell trafficking.
Treatment of animals and cells with a mAb to L-selectin
had no effect (Fig. 2 C), whereas mAbs to P- and E-selec-
tin reduced rolling by 58 and 32%, respectively. Impor-
tantly, although endothelial cells in other organs such as the
mesentery or cremaster muscle may require prior cytokine
activation or other inflammatory stimuli to support rolling
interactions via endothelial selectins (27–29), BM venules
and sinusoids supported FDCP-mix cell rolling constitu-
tively. Although it can not be excluded that the surgical ex-
Table 1. Dimensions and Hemodynamic Parameters of BM and Bone Microvessels
Parameters BMCV Sinusoids BMPSV BMIV BV
n (venules/animals) 16/5 14/5 5/5 19/5 8/3
Diameter (mm) 98.8 6 12  41.9 6 10.8  56.2 6 11.9  28.8 6 9.1  21.6 6 7.9 
(89.3–126.6) (21.9–60.2) (47.6–74.8) (17.0–50.4) (13.7–36.8)
Vrbc (mm/sec) 525.0 6 293.3 418.0 6 126.2 508.6 6 190.9 196.9 6 153.2 222.7 6 124.3
(120.9–1220.1) (255.1–731.6) (385.0–842.1) (88.2–750.2) (75.3–385.2)
WSR (sec21) 91.7 6 43.6 91.4 6 36.9 76.9 6 19.9 56.9 6 33.6 98.6 6 28.5
(23.7–167.9) (50.5–164.8) (54.5–98.1) (15.2–130.6) (53.3–144.9)
To assess BM microhemodynamics, fluorescently labeled murine erythrocytes were injected intraarterially and their velocity in venules and sinusoids
was determined by off-line video analysis (17). Since rheologic parameters in BMCVs were often different in individual segments of the same venule
upstream and downstream of bifurcations, these vascular segments were analyzed separately. VRBC, red blood cell velocity; WSR, wall shear rate.
Data are presented as arithmetic mean 6 SD, and ranges are given in parentheses.470 Progenitor Cell Rolling in BM Microvessels
posure of the skull may have induced some tissue irrita-
tion, the time course of these experiments (typically ,1 h)
was too short for significant transcriptional induction of
E-selectin (30). Moreover, inflammation-induced rapid up-
regulation of P-selectin from Weibel-Palade bodies would
likely affect all exposed venules. BVs in immediate vicinity
to BM venules and sinusoids did not support rolling, sug-
gesting that BM vessels express endothelial selectins consti-
tutively and selectively. This interpretation is consistent with
recent reports of E-selectin expression in noninflamed mu-
rine and human BM, detected by immunohistology or re-
verse-transcriptase PCR of noninflamed endothelial cells
(8, 14), and with in vitro studies that have shown E-selec-
tin–mediated rolling of human HPCs on cultured BM en-
dothelial cells (8).
FDCP-mix Cells Interact with BM Microvessels in Mice De-
ficient in P/E-selectin. Although P- and E-selectin inhibi-
tion significantly reduced FDCP-mix cell rolling, the mAbs
did not block interactions by .68%, even given in combi-
nation. To test whether rolling could occur in the com-
plete absence of selectins, we used P/E-selectin doubly-
deficient mice (14). Rolling of FDCP-mix cells in BM
venules and sinusoids of these animals was lower than in
wild-type littermates, consistent with a role for endothelial
selectins in stem cell homing to BM. However, a signifi-
cant fraction of cells continued to roll, and this interaction
was not affected by inhibition of L-selectin (Fig. 2 D).
Thus, additional selectin-independent adhesion mecha-
nism(s) that are sufficient to support tethering and rolling of
circulating HPCs in BM microvessels must exist.
Figure 2. FDCP-mix cells roll in BM venules and sinusoids. (A) Micrograph of a segment
of the right parietal sinusoidal network. Blood flow in some vessels is indicated by arrowheads.
To improve contrast between the intra- and extravascular compartment, this animal was in-
jected intravenously with low-dose FITC-dextran (150 kD, 10 mg/g body weight). Three
BCECF-labeled FDCP-mix cells (bright intravascular dots) can be seen. (B) Comparison of
FDCP-mix cell rolling fractions in BM and bone venules. Rolling fractions in all types of BM
venules and sinusoids were significantly higher than in BVs (Student’s two-tailed t test for un-
paired data). Therefore, data from BM vessels were pooled for this figure. Data are shown as
mean 6 SEM. n, number of venules. (C) Role of selectins in FDCP-mix cell rolling in wild-
type mice. FDCP-mix cell rolling was measured in the same BM vessels before and after injec-
tion of anti–P- and/or anti–E-selectin mAbs (100 mg/mouse) or treatment of cells with anti–
L-selectin mAb (100 mg/107 cells). Each bar represents the mean 6 SEM of three experiments.
n corresponds to the number of venules. Groups were compared with control using the Kruskal-Wallis test followed by Bonferoni correction of P. (D) Com-
parison of FDCP-mix cell rolling in wild-type and P/E-selectin double knockout mice. Data are expressed as mean 6 SEM of three experiments. Rolling
fractions in P/E-deficient mice were significantly lower than in wild-type littermates (P ,0.001; Student’s t test), but were not affected by anti–L-selectin
mAb (100 mg/107 cells). n, number of venules.471 Mazo et al.
Constitutively Expressed VCAM-1 Mediates Selectin-inde-
pendent Rolling of FDCP-mix and M1 Progenitors in BM Micro-
vessels. We hypothesized that VCAM-1 could be responsible
for selectin-independent rolling. In vitro experiments have
shown that VCAM-1 interaction with a4 integrins mediates
lymphocyte tethering and rolling (31–33). Furthermore,
immunohistochemical studies on sections of murine and hu-
man BM have shown that VCAM-1 is constitutively ex-
pressed in BM microvessels (7, 8). To determine whether
VCAM-1 is present in murine skull caps, we injected fluo-
resceinated anti–VCAM-1 mAb (MK 2.7, F/P ratio 2.85)
into mice. Within 10 min after injection, antibody accu-
mulation was detectable at the luminal surface of BM
venules and sinusoids (Fig. 3 A). In contrast, mAb binding
was undetectable in most BV and in subdermal venules of
the animals’ ears, and BM vessels did not bind a mAb to the
mucosal addressin MAdCAM-1 (MECA-367, F/P ratio
6.94; data not shown).
To test whether VCAM-1 and a4 integrins mediate
FDCP-mix cell rolling, we used mAbs against these mole-
cules. Both antibodies decreased rolling fractions in wild-
type animals by 35–50% (Fig. 3 B), whereas rolling was in-
hibited by z75% in P/E-selectin-deficient mice (Fig. 3 C),
indicating that a4/VCAM-1 alone can initiate and sustain
cell–cell interactions in BM venules and sinusoids. Both
mAbs inhibited rolling equally, suggesting that other a4
ligands did not participate. Most of the rare cells that inter-
acted with P/E-selectin-deficient BM vessels after inhibi-
tion of VCAM-1 rolled only briefly and typically detached
within seconds, indicating that a4/VCAM-1 is the major
selectin-independent rolling pathway.
Although a4-mediated rolling on purified, immobilized
VCAM-1 or on transfectants is well documented (31–33),
several in vitro studies of monocyte and T cell adhesion to
endothelial monolayers were unable to demonstrate in-
volvement of this pathway in rolling (33, 34). In these ex-
periments, monocytes and T cells engaged with VCAM-1
only during firm adhesion and transendothelial migration.
On the other hand, intravital microscopy studies of eosino-
phil and lymphocyte adhesion to inflamed mesenteric or
cremaster muscle venules suggest that a4 integrins can sup-
port rolling in those tissues in synergy with, but not inde-
pendent of, selectins (35–37). This variability in a4/
VCAM-1–dependent adhesion could be due to several fac-
tors. First, the mode of VCAM-1 expression may vary.
This may involve VCAM-1 surface density, ultrastructural
presentation, host cell–specific posttranslational modifica-
tion(s), or a combination of these factors. Although fluores-
cent signals from BM microvessels were partially absorbed
by overlying tissues, and the skull itself emitted significant
background fluorescence, labeled VCAM-1 mAb was readily
visualized in BM microvessels, suggesting that VCAM-1
expression was high. Second, the differences may reflect
variable levels of a4 affinity and/or avidity that may be host
cell–dependent (38). However, rolling on VCAM-1 was
not unique for FDCP-mix cells since rolling of the myeloid
progenitor line M1 (16) was also blocked by anti-a4.
Endothelial Selectins and VCAM-1 Mediate Rolling of FL
HPC in BM Microvessels. The fact that fluorescent VCAM-1
mAb was readily visualized in BM microvessels, even un-
der conditions that are likely to render our method of de-
tection relatively insensitive, suggests that VCAM-1 is ex-
Figure 3. The a4/VCAM-1 pathway mediates selectin-independent rolling of progenitor cells in BM microvessels. (A) CFSE-labeled anti–VCAM-1
accumulation in a typical BM venule. 50 mg of fluorescently labeled mAb MK 2.7 was injected intravenously. 15 min later, the animal was anesthetized,
the vena cava was cut, and the mouse was perfused through a catheter in the right common carotid artery with heparinized ice-cold saline to remove in-
travascular blood and unbound mAb. The optical plane was focused on the centerline of the venule revealing fluorescent mAb at the luminal surface of
opposing vessel walls (upward curved horizontal lines). Scale bar depicts 50 mm. (B and C) Effect of mAbs against integrins and VCAM-1 in (B) wild-type
mice and (C) P/E-selectin double knockout mice. Rolling fractions after mAb treatment were normalized to rolling fractions determined in the same
vessel before mAb application (control). Only FDCP-mix cells were tested in P/E-selectin knockout animals. Groups were compared with control using
the Kruskal-Wallis test with Bonferoni correction of P (for FDCP-mix cells) or the Student’s two-tailed t test for paired data (for M1 cells). All data are
shown as mean 6 SEM of three independent experiments. n, number of venules per group.472 Progenitor Cell Rolling in BM Microvessels
pressed at considerable levels on the luminal surface of BM
venules and sinusoids. Moreover, our studies with neutral-
izing mAbs clearly demonstrate that VCAM-1 mediates
rolling of progenitor cell lines, presumably via interactions
with a4b1 (VLA-4). However, FDCP-mix and M1 cells ex-
press also a4b7, which could have interacted weakly with
VCAM-1. This integrin is absent on human (9) and murine
(Mazo, I.B., and U.H. von Andrian, unpublished data) HPCs.
Thus, although our studies with FDCP-mix cells demonstrate
that a4/VCAM-1 can mediate selectin-independent rolling in
vivo, it could be argued that native HPCs may not be able to
use this pathway because their a4 integrins may have a differ-
ent composition or functional activity.
Because it was not possible to isolate HPCs from adult
mice at sufficient quantity and purity for in vivo experi-
ments, we harvested FL cells from murine embryos at day
11 of gestation. HPCs from FLs were shown to home to the
BM similarly to HPCs from adult BM (39). At day 11, mu-
rine FLs contain z50% erythroid cells (Ter-1191) and
z50% MNCs (Ter-1192, c-kit1) (40). Approximately half
of the latter are uncommitted HPCs. The rest are bipotent
progenitors of B cell/macrophage lineage (41). Flow cyto-
metric analysis of FL cells confirmed these observations and
revealed that Ter-1192 c-kit1 cells (HPCs) stained brightly
with the fluorophore BCECF, whereas the fluorescence in-
tensity of BCECF-labeled Ter-1191 cells was 10–100-fold
lower (data not shown). Control experiments revealed that
most erythroid cells were thus below the detection thresh-
old of our video camera. Therefore, we did not separate
erythroid cells from HPCs because the latter constituted the
vast majority (z90%) of detectable FL cells in BM vessels.
Rolling of FL HPCs in BM venules and sinusoids of
wild-type mice was comparable to that of FDCP-mix cells
(mean 6 SEM of rolling fractions: 21.9 6 4.9% for FL
HPC vs. 19.9 6 1.5% for FDCP-mix). Rolling was also
markedly inhibited by anti–VCAM-1 (Fig. 4). Likewise,
FL HPC rolling in P/E-selectin knockout mice was lower
than in wild-type BM, and was nearly abolished after addi-
tional inhibition of VCAM-1. We conclude that FL HPC
and likely other HPC populations behave equivalently to
progenitor cell lines in that they are able to use either vas-
cular selectins or the a4b1/VCAM-1 pathway to initiate
rolling. However, it should be noted that FL HPC, unlike
progenitor cell lines, could be composed of different sub-
populations whose rolling may be preferentially supported
by one or the other mechanism.
Endothelial Specialization in BM Microvessels: Implications for
HPC Homing. The parallel contribution by distinct con-
stitutive rolling pathways in adult BM microvessels may
function as a safeguard to provide access for circulating
HPCs to areas where resident HPCs have been lost. It may
similarly ensure sufficient seeding of the BM during fetal
development. This could explain why a deficiency in P-
and/or E-selectin or their fucosylated ligands does not
abolish hematopoiesis in gene-targeted mice (14, 42). Sim-
ilarly, a defect in fucose metabolism in humans with leuko-
cyte adhesion deficiency syndrome type 2 causes a com-
plete absence of selectin ligands resulting in increased
susceptibility to infections (43). However, hematopoiesis in
these patients is intact, presumably because HPCs can still
use a4/VCAM-1 to reach the BM.
A similar evaluation of a4 or VCAM-1 in gene-targeted
mice is more complex because either null mutation is em-
bryonic lethal before the BM is formed (44). However,
hematopoiesis has been examined in animals that express a
hypomorphic VCAM-1 mutant (1), and in chimeric mice
that lack a4 integrins on hematopoietic cell subsets (45).
Together, these studies indicate that defects in endothelial
selectins or in a4/VCAM-1 can lead to abnormalities in
blood cell production or differentiation, but neither of these
pathways alone is essential for HPC homing to the BM.
Our findings are consistent with this interpretation; endo-
thelial selectins and VCAM-1 could independently initiate
and sustain HPC adhesion in BM venules and sinusoids.
HPC migration from FL to BM during fetal develop-
ment occurs in a sterile uterine environment and involves a
large number of HPCs that colonize the BM during ongo-
ing extramedullary hematopoiesis (39). In contrast, patients
undergoing BM ablation for HPC transplantation are not
similarly well protected. Intravenously transplanted HPCs
are likely to use the same adhesion pathways to reach he-
matopoietic compartments in the BM. Indeed, antibodies
to VCAM-1 and/or a4 were shown to reduce the number
of homed HPCs in the BM of lethally irradiated mice by
z50% (5). The partial preservation of HPC homing in
these experiments is consistent with a contribution by P-
and E-selectin, but the role of endothelial selectins in he-
matopoietic recovery after HPC transplantation has not
been examined so far. A clinical study has reported that the
number of L-selectinhi HPCs in BM grafts correlated with
faster recovery of thrombopoiesis (10), but it is unclear
whether this is an effect of differential HPC migration. Our
observations suggest that L-selectin does not contribute to
HPC homing, at least in unchallenged BM. It is possible
that conditioning with chemotherapy or irradiation before
transplantation may induce changes in BM endothelial cells
(7). However, a recent report has shown that short-term
homing of HPCs to irradiated BM is lower than to un-
treated BM (46). Thus, it is unclear whether irradiation
promotes HPC seeding of the BM because of enhanced
HPC recruitment from the blood or because of other ef-
fects such as an increased accessibility of extravascular sites
that promote HPC survival and hematopoiesis.
Figure 4. Fluorescently la-
beled HPC from day 11 FLs of
C57/B6J embryos were analyzed
in BM microvessels of wild-type
and P/E-selectin–deficient mice
before and after treatment with
anti–VCAM-1 (100 mg/mouse).
Data in wild-type mice are from
three independent experiments.
FL HPC rolling was determined
in three P/E-selectin-deficient
mice, and one of these animals was additionally treated with anti–VCAM-1.
All bars depict mean 6 SEM. n, number of venules. Groups were com-
pared using Student’s t test for paired or unpaired data where appropriate.473 Mazo et al.
Nevertheless, it appears reasonable that the kinetics of he-
matopoietic recovery after HPC transplantation correlate
with the efficacy of HPC homing to the BM, particularly
when the number of HPCs is limited. Thus, a defect or re-
duced efficacy of selectin ligands or a4b1 might reduce HPC
homing and prolong the period during which patients are at
risk of infection or bleeding. This could be particularly im-
portant for therapies using highly purified autologous HPCs
or transfected HPCs as a treatment of cancer or genetic defi-
ciencies. Methods of transfection and cultivation of HPCs
have been reported (47, 48), but the effects of these manipu-
lations on HPC expression of selectin ligands and a4b1 have
not been examined. Based on our findings, we speculate that
culture conditions or other manipulations that preserve or en-
hance the ability of HPCs to interact with vascular selectins
or VCAM-1 may have beneficial effects on the homing of
transfused cells to a recipient’s BM.
In conclusion, our experiments assign a pivotal function to
P/E-selectin and VCAM-1 as endothelial determinants that
initiate adhesion between BM endothelial cells and circulat-
ing HPCs. However, our findings do not exclude a role for
chemoattractants or other adhesion molecules that may be
critical for firm arrest of rolling cells or subsequent diapedesis.
Indeed, unique combinations of rolling receptors, chemoat-
tractants, and secondary adhesion molecules direct the specific
migration of differentiated myeloid and lymphoid cells to
other organs (3, 4, 49). While some molecules participate in
many adhesion cascades, others function selectively in special-
ized vascular beds such as the high endothelial venules of peri-
pheral lymph nodes and Peyer’s patches (49). These so-called
vascular addressins constitute a single molecular species or an-
tigenic determinant and act as highly efficient rolling recep-
tors. The adhesion-initiating vascular addressins of the BM
differ from their counterparts in high endothelial venules in-
asmuch as they are not a single endothelial determinant but a
unique combination of adhesion molecules that appear to
make equivalent parallel contributions during HPC homing.
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